| Literature DB >> 29758071 |
Lu Gram1, Jolene Skordis-Worrall1, Dharma S Manandhar2, Daniel Strachan1, Joanna Morrison1, Naomi Saville1, David Osrin1, Kirti M Tumbahangphe2, Anthony Costello1,3, Michelle Heys1,4.
Abstract
Women's groups practicing participatory learning and action (PLA) in rural areas have been shown to improve maternal and newborn survival in low-income countries, but the pathways from intervention to impact remain unclear. We assessed the long-term impact of a PLA intervention in rural Nepal on women's agency in the household. In 2014, we conducted a follow-up study to a cluster randomised controlled trial on the impact of PLA women's groups from 2001-2003. Agency was measured using the Relative Autonomy Index (RAI) and its subdomains. Multi-level regression analyses were performed adjusting for baseline socio-demographic characteristics. We additionally adjusted for potential exposure to subsequent PLA groups based on women's pregnancy status and conduct of PLA groups in areas of residence. Sensitivity analyses were performed using two alternative measures of agency. We analysed outcomes for 4030 mothers (66% of the cohort) who survived and were recruited to follow-up at mean age 39.6 years. Across a wide range of model specifications, we found no association between exposure to the original PLA intervention with women's agency in the household approximately 11.5 years later. Subsequent exposure to PLA groups was not associated with greater agency in the household at follow-up, but some specifications found evidence for reduced agency. Household agency may be a prerequisite for actualising the benefits of PLA groups rather than a consequence.Entities:
Mesh:
Year: 2018 PMID: 29758071 PMCID: PMC5951552 DOI: 10.1371/journal.pone.0197426
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Implementation of participatory women’s groups.
Vertical lines indicate exposure to an intervention. The total number of women interviewed refers to the number of women for which their household agency was measured at endline.
Fig 2Trial flow for the data collection process.
Baseline characteristics disaggregated by availability for interview.
All values except deliveries in Periods B-E (see Fig 1) refer to measurements at baseline.
| Status at follow-up in 2014 | |||||
|---|---|---|---|---|---|
| Exposure to the original Makwanpur trial | Exposure to the original Makwanpur trial | ||||
| Total count | |||||
| Total no. of women | 1989 | 2041 | 826 | 1129 | 5985 |
| Janajati | 75% (1495) | 82% (1670) | 67% (548) | 80% (899) | 77% (4612) |
| Newar | 3% (50) | 2% (38) | 3% (23) | 2% (23) | 2% (134) |
| Brahmin/Chhetri | 17% (344) | 12% (239) | 24% (197) | 13% (142) | 15% (922) |
| Dalit | 4% (83) | 4% (73) | 5% (44) | 5% (52) | 4% (252) |
| Other | 1% (12) | 1% (19) | 1% (6) | 1% (7) | 1% (44) |
| Agriculture | 88% (1743) | 95% (1945) | 85% (696) | 95% (1071) | 91% (5455) |
| Waged labour | 8% (154) | 3% (63) | 10% (79) | 2% (24) | 5% (320) |
| Salaried/government job | 3% (54) | 1% (17) | 3% (26) | 1% (11) | 2% (108) |
| Small business | 2% (33) | 1% (14) | 2% (17) | 2% (17) | 1% (81) |
| None | 52% (1027) | 56% (1139) | 51% (416) | 56% (634) | 54% (3216) |
| Clock, radio, iron or bicycle | 32% (630) | 35% (722) | 31% (256) | 35% (388) | 33% (1996) |
| More costly assets | 16% (327) | 9% (178) | 18% (146) | 9% (101) | 13% (752) |
| No education | 77% (1531) | 87% (1768) | 70% (575) | 85% (956) | 81% (4830) |
| 1–3 years | 8% (159) | 4% (87) | 8% (63) | 5% (53) | 6% (362) |
| 4–8 years | 12% (247) | 8% (153) | 18% (149) | 8% (93) | 11% (642) |
| 9+ years | 2% (47) | 2% (31) | 4% (31) | 2% (21) | 2% (130) |
| <25 years' old | 42% (840) | 39% (789) | 50% (413) | 46% (512) | 43% (2554) |
| 25–29 years' old | 26% (520) | 27% (545) | 25% (206) | 22% (248) | 25% (1519) |
| 30+ years' old | 31% (624) | 35% (705) | 24% (199) | 32% (363) | 32% (1891) |
| Male | 92% (1819) | 95% (1936) | 90% (737) | 96% (1077) | 93% (5569) |
| Female | 8% (165) | 5% (103) | 10% (81) | 4% (46) | 7% (395) |
| Delivered in Period A | 100% (1989) | 100% (2041) | 100% (826) | 100% (1129) | 100% (5985) |
| Delivered in Period B | 15% (290) | 11% (233) | 12% (103) | 9% (107) | 12% (733) |
| Delivered in Period C | 29% (572) | 41% (845) | 20% (164) | 27% (301) | 31% (1882) |
| Delivered in Period D | 1% (26) | 3% (56) | 1% (9) | 1% (13) | 2% (104) |
| Delivered in Period E | 2% (42) | 4% (73) | 1% (7) | 2% (17) | 2% (139) |
| 5 | 2 | 8 | 6 | 21 | |
Descriptive statistics collected from respondents upon follow-up.
n = 4030. †6 respondents had missing values on health-seeking behaviour. ‡19 respondents had missing values on group participation. • Values reported in the format mean (SD). Scores for agency freedom are raw, unstandardized scores.
| Exposure to the original Makwanpur trial | ||||
|---|---|---|---|---|
| Sample size | 1989 | 2041 | 4030 | |
| Employment | Respondent works outside the home | 99% (1963) | 100% (2032) | 99% (3995) |
| Respondent does not work outside | 1% (26) | 0% (9) | 1% (35) | |
| Domestic work | Respondent is main person responsible for cooking, cleaning and laundry | 46% (924) | 61% (1237) | 54% (2161) |
| Respondent is responsible for managing money and doing the shopping | 41% (825) | 30% (615) | 36% (1440) | |
| Place of health-seeking† | Public/private facility | 75% (1493) | 52% (1064) | 64% (2557) |
| Pharmacy/shop | 22% (444) | 43% (882) | 33% (1326) | |
| Other (incl. traditional healer) | 1% (10) | 2% (45) | 1% (55) | |
| Doesn't do anything | 2% (42) | 2% (44) | 2% (86) | |
| Group participation‡ | 26% (515) | 43% (866) | 34% (1381) | |
| Mainly employment-related | 2% (38) | 3% (69) | 3% (107) | |
| Mainly finance-related | 68% (1344) | 49% (995) | 58% (2339) | |
| Mainly health-related | 2% (35) | 2% (32) | 2% (67) | |
| Other | 3% (56) | 3% (61) | 3% (117) | |
| Agency freedom• | Overall agency (-12 to +12) | 9.9 (2.0) | 9.4 (2.3) | 9.6 (2.2) |
| Agency in employment (-3 to +3) | 2.6 (0.7) | 2.8 (0.6) | 2.7 (0.7) | |
| Agency in domestic work (-3 to +3) | 2.8 (0.6) | 2.8 (0.5) | 2.8 (0.6) | |
| Agency in health-seeking (-3 to +3) | 2.2 (0.8) | 2.0 (0.8) | 2.1 (0.8) | |
| Agency in group participation (-3 to +3) | 2.2 (1.1) | 1.8 (1.3) | 2.0 (1.2) | |
| Financial decision-making power | Only woman herself makes decisions | 11% (222) | 10% (195) | 10% (417) |
| Woman and other household members make decisions jointly | 77% (1531) | 80% (1633) | 79% (3164) | |
| Woman not involved in decisions | 12% (236) | 10% (213) | 11% (449) | |
| Ladder question | Current step (1 to 10) | 4.2 (1.5) | 4.6 (1.6) | 4.4 (1.6) |
Impact estimates of the effect of exposure to the original Makwanpur intervention on overall agency measured with the RAI.
Effect sizes in standard deviations. 95% confidence intervals in brackets.
| Model no. | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
| Original trial intervention | 0.18 (-0.31, 0.68) | 0.17 (-0.32, 0.66) | 0.17 (-0.32, 0.65) | 0.26 (-0.24, 0.77) | 0.08 (-0.51, 0.66) | 0.12 (-0.47, 0.71) |
| IMPEXP(0) | -0.07 | |||||
| IMPEXP(0.5) | -0.13 | |||||
| IMPEXP(1) | 0.05 (-0.16, 0.26) | 0.01 (-0.20, 0.22) | ||||
| DELIVERIES | -0.03 | -0.03 | -0.03 | -0.04 | ||
| Sample size | 4030 | 4023 | 3963 | 3963 | 3963 | 1487 |
Model specifications were as follows
Model 1. Unadjusted association of residence in intervention/control of the original trial with household agency
Model 2. Model 1 + controls for maternal education and age, household asset index, caste/ethnicity, household occupation and sex of household head
Model 3. Model 2 + controls for baseline no. deliveries and subsequent exposure to PLA groups counting only pregnancy-associated exposure
Model 4. Model 2 + controls for baseline no. deliveries and subsequent exposure to PLA groups weighting non pregnancy-associated exposure half as highly as pregnancy-associated exposure
Model 5. Model 2 + controls for baseline no. deliveries and subsequent exposure to PLA groups weighting non pregnancy-associated exposure equally highly to pregnancy-associated exposure
Model 6. Model 5 using a sample restricted to women who never delivered after the end of the original trial and never became mothers-in-law
* p<0.05
** p<0.01
*** p<0.001
# Baseline number of deliveries: 14110 (Models 3–5), 4122 (Model 6).
† 7 women had missing data in at least one of the control covariates
¶ 53 additional women had missing data on baseline number of deliveries
ǂ2476 additional women excluded as they either became mothers-in-law themselves or delivered after the end of the original trial
Impact estimates of the effect of exposure to the original Makwanpur intervention on sub-domains of the overall agency score.
Effect sizes in standard deviations. 95% confidence intervals in brackets.
| Model no. | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
| Trial intervention | -0.17 (-0.53, 0.19) | -0.15 (-0.51, 0.20) | -0.16 (-0.51, 0.20) | -0.14 (-0.51, 0.23) | -0.17 (-0.60, 0.26) | -0.09 (-0.54, 0.37) |
| IMPEXP(0) | -0.02 (-0.08, 0.05) | |||||
| IMPEXP(0.5) | -0.02 (-0.15, 0.10) | |||||
| IMPEXP(1) | 0.01 (-0.14, 0.16) | -0.03 (-0.19, 0.13) | ||||
| DELIVERIES | -0.01 (-0.02, 0.01) | -0.01 (-0.02, 0.01) | -0.01 (-0.02, 0.01) | 0.00 (-0.03, 0.03) | ||
| Trial intervention | 0.00 (-0.41, 0.41) | 0.00 (-0.41, 0.41) | -0.01 (-0.42, 0.40) | -0.03 (-0.46, 0.39) | 0.04 (-0.46, 0.53) | 0.16 (-0.37, 0.69) |
| IMPEXP(0) | 0.02 (-0.05, 0.09) | |||||
| IMPEXP(0.5) | 0.03 (-0.10, 0.15) | |||||
| IMPEXP(1) | -0.03 (-0.21, 0.14) | -0.06 (-0.25, 0.13) | ||||
| DELIVERIES | -0.01 (-0.02, 0.01) | -0.01 (-0.02, 0.01) | -0.01 (-0.02, 0.01) | -0.03 (-0.05, 0.01) | ||
| Trial intervention | 0.23 (-0.29, 0.75) | 0.22 (-0.29, 0.73) | 0.23 (-0.28, 0.74) | 0.27 (-0.25, 0.79) | 0.15 (-0.47, 0.77) | 0.18 (-0.44, 0.80) |
| IMPEXP(0) | -0.03 (-0.09, 0.02) | |||||
| IMPEXP(0.5) | -0.06 (-0.16, 0.05) | |||||
| IMPEXP(1) | 0.05 (-0.18, 0.27) | 0.03 (-0.20, 0.26) | ||||
| DELIVERIES | -0.01 (-0.02, 0.00) | -0.01 (-0.02, 0.00) | -0.01 (-0.02, 0.00) | -0.01 (-0.04, 0.01) | ||
| Trial intervention | 0.26 (-0.07, 0.59) | 0.23 (-0.09, 0.55) | 0.23 (-0.07, 0.54) | 0.35 (-0.01, 0.71) | 0.10 (-0.26, 0.47) | 0.07 (-0.29, 0.44) |
| IMPEXP(0) | -0.11 | |||||
| IMPEXP(0.5) | -0.15 | |||||
| IMPEXP(1) | 0.07(-0.06, 0.20) | 0.04 (-0.09, 0.17) | ||||
| DELIVERIES | -0.04 | -0.04 | -0.04 | -0.05 | ||
| Sample size | 4030 | 4023 | 3963 | 3963 | 3963 | 1487 |
* p<0.05
** p<0.01
*** p<0.001
#baseline number of deliveries: 14110 (Models 3–5), 4122 (Model 6).
† 7 women had missing data in at least one of the control covariates
¶ 53 additional women had missing data on baseline number of deliveries
ǂ2476 additional women excluded as they either became mothers-in-law themselves or delivered after the end of the original trial
Fig 3Estimates from models on the effect of the original Makwanpur intervention and subsequent exposure after varying θ in IMPEXP(θ).
Effect sizes are in units of standard deviations of the overall agency measured with the RAI. Bands around point estimates of effect sizes represent 95% confidence intervals.θ refers to the weight given to exposure to PLA groups while non-pregnant. When θ we control exclusively for later exposure while pregnant. When θ = 1, we weight exposure to PLA groups while pregnant and non-pregnant equally.
Impact estimates of the effect of exposure to the original Makwanpur intervention on alternative measures of agency.
95% confidence intervals in brackets. Effect sizes in logits for financial power. Effect sizes in steps on the Power Ladder (out of 10) for the Power Ladder question.
| Model no. | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
| Trial intervention | -0.16 (-0.87, 0.56) | -0.21 (-0.92, 0.51) | -0.20 (-0.91, 0.51) | -0.09 (-0.89, 0.71) | -0.18 (-0.95, 0.59) | -0.28 (-1.33, 0.77) |
| IMPEXP(0) | -0.25 (-0.57, 0.08) | |||||
| IMPEXP(0.5) | -0.17 (-0.72, 0.38) | |||||
| IMPEXP(1) | -0.04 (-0.41, 0.34) | -0.07 (-0.44, 0.31) | ||||
| DELIVERIES | -0.04 (-0.10, 0.02) | -0.04 (-0.10, 0.02) | -0.04 (-0.10, 0.03) | -0.13 (-0.27, 0.01) | ||
| Trial intervention | -0.27 (-0.66, 0.11) | -0.45 | -0.43 | -0.02 (-0.41, 0.36) | -0.39 (-0.79, 0.02) | -0.53 |
| IMPEXP(0) | -0.33 | |||||
| IMPEXP(0.5) | -0.52 | |||||
| IMPEXP(1) | -0.06 (-0.21, 0.09) | -0.07 (-0.23, 0.09) | ||||
| DELIVERIES | -0.09 | -0.09 | -0.09 | -0.11 | ||
| Sample size | 4030 | 4023 | 3963 | 3963 | 3963 | 1487 |
* p<0.05
** p<0.01
*** p<0.001.
# baseline number of deliveries: 14110 (Models 3–5), 4122 (Model 6).
† 7 women had missing data in at least one of the control covariates
¶ 53 additional women had missing data on baseline number of deliveries
ǂ2476 additional women excluded as they either became mothers-in-law themselves or delivered after the end of the original trial